Inovalon Holdings Inc (NASDAQ:INOV) was down 7.6% during mid-day trading on Monday . The stock traded as low as $12.85 and last traded at $14.05. Approximately 2,067,490 shares changed hands during trading, an increase of 156% from the average daily volume of 807,838 shares. The stock had previously closed at $15.20.

Several equities research analysts have recently issued reports on INOV shares. Morgan Stanley upgraded Inovalon from an “underweight” rating to an “equal weight” rating and lifted their price target for the company from $9.00 to $14.00 in a report on Tuesday, September 12th. KeyCorp reiterated a “hold” rating on shares of Inovalon in a report on Tuesday, September 12th. TheStreet upgraded Inovalon from a “d+” rating to a “c-” rating in a report on Thursday, October 5th. Zacks Investment Research lowered Inovalon from a “hold” rating to a “sell” rating in a report on Tuesday, November 7th. Finally, BidaskClub lowered Inovalon from a “hold” rating to a “sell” rating in a report on Saturday, December 2nd. Two research analysts have rated the stock with a sell rating and six have issued a hold rating to the company. The company has an average rating of “Hold” and a consensus price target of $12.00.

The company has a debt-to-equity ratio of 0.31, a quick ratio of 5.62 and a current ratio of 5.62. The firm has a market capitalization of $2,050.00 and a P/E ratio of 117.08.

Inovalon (NASDAQ:INOV) last issued its quarterly earnings data on Wednesday, November 1st. The technology company reported $0.09 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.08 by $0.01. Inovalon had a return on equity of 4.63% and a net margin of 4.07%. The business had revenue of $115.90 million for the quarter, compared to the consensus estimate of $114.79 million. During the same period last year, the business earned $0.10 EPS. The firm’s revenue was up 10.4% compared to the same quarter last year. sell-side analysts expect that Inovalon Holdings Inc will post 0.24 EPS for the current fiscal year.

In related news, insider Shauna L. Vernal sold 5,908 shares of the firm’s stock in a transaction that occurred on Friday, November 17th. The stock was sold at an average price of $16.01, for a total value of $94,587.08. Following the transaction, the insider now directly owns 47,309 shares of the company’s stock, valued at approximately $757,417.09. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, President Robert A. Wychulis sold 85,828 shares of the firm’s stock in a transaction that occurred on Tuesday, December 5th. The shares were sold at an average price of $15.54, for a total value of $1,333,767.12. Following the completion of the transaction, the president now directly owns 466,286 shares in the company, valued at $7,246,084.44. The disclosure for this sale can be found here. 48.28% of the stock is currently owned by company insiders.

Several hedge funds have recently modified their holdings of INOV. Schwab Charles Investment Management Inc. raised its stake in shares of Inovalon by 93.9% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 290,293 shares of the technology company’s stock valued at $3,818,000 after acquiring an additional 140,566 shares in the last quarter. Rhumbline Advisers raised its stake in shares of Inovalon by 10.8% in the 2nd quarter. Rhumbline Advisers now owns 68,592 shares of the technology company’s stock valued at $902,000 after acquiring an additional 6,673 shares in the last quarter. Bank of New York Mellon Corp increased its position in Inovalon by 9.9% in the 2nd quarter. Bank of New York Mellon Corp now owns 344,848 shares of the technology company’s stock worth $4,535,000 after buying an additional 30,922 shares during the period. Legal & General Group Plc increased its position in Inovalon by 2,696.8% in the 2nd quarter. Legal & General Group Plc now owns 16,417 shares of the technology company’s stock worth $216,000 after buying an additional 15,830 shares during the period. Finally, BNP Paribas Arbitrage SA increased its position in Inovalon by 336.2% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 8,397 shares of the technology company’s stock worth $110,000 after buying an additional 6,472 shares during the period. 28.08% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: “Inovalon (INOV) Stock Price Down 7.6%” was reported by Watch List News and is the sole property of of Watch List News. If you are reading this article on another site, it was illegally stolen and republished in violation of international copyright & trademark law. The correct version of this article can be accessed at https://www.watchlistnews.com/inovalon-inov-stock-price-down-7-6/1799010.html.

About Inovalon

Inovalon Holdings, Inc (Inovalon) is a technology company. The Company provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models to the healthcare industry. Leveraging large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and subject matter expertise, Inovalon enables the assessment and improvement of clinical and quality outcomes and financial performance across the healthcare ecosystem.

Receive News & Ratings for Inovalon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon and related companies with Analyst Ratings Network's FREE daily email newsletter.